Summary of Key Information:
Reporting Period (Quarter/Year): Quarter and Half Year ended 30th September, 2026 (Q2 FY27)
Nature of Filing / Announcement: Outcome of Board Meeting
Date of Board Meeting / Approval: 4th November, 2026
Audit Opinion: Clean (Unmodified) - Limited Review Report states nothing has come to their attention to believe the statement contains any material misstatement.
Auditor’s Comment: Not Specified
Key Financial Highlights [in lakhs]
Standalone Results:
Revenue from Operations:
- Q2 FY27: ₹187,628.11 (Unaudited)
- Q1 FY27: ₹163,679.30 (Unaudited) [QoQ Growth: 14.6%]
- Q2 FY26: ₹167,076.34 (Unaudited) [YoY Growth: 12.3%]
Total Income:
- Q2 FY27: ₹190,984.82 (Unaudited)
Net Profit:
- Q2 FY27: ₹9,592.79 (Unaudited)
- Q2 FY26: ₹4,595.32 (Unaudited) [YoY Growth: 108.7%]
EPS (not annualised):
- Basic: ₹4.54 (Q2 FY27) vs ₹2.28 (Q2 FY26)
- Diluted: ₹4.50 (Q2 FY27) vs ₹2.26 (Q2 FY26)
Other Equity:
- As at 31-03-2026 (Audited): ₹387,227.33
Cash and Cash Equivalents:
- As at 30-09-2026 (Unaudited): ₹43,586.87
Debt:
- Non-Current Borrowings: As at 30-09-2026: ₹124,071.93
- Current Borrowings: As at 30-09-2026: ₹30,298.45
- Total Borrowings: ₹154,370.38
Consolidated Results:
Revenue from Operations:
- Q2 FY27: ₹187,628.11 (Unaudited)
Net Profit (attributable to owners):
- Q2 FY27: ₹10,229.21 (Unaudited)
- Q2 FY26: ₹5,389.17 (Unaudited) [YoY Growth: 89.8%]
EPS (not annualised):
- Basic: ₹4.84 (Q2 FY27) vs ₹2.67 (Q2 FY26)
- Diluted: ₹4.80 (Q2 FY27) vs ₹2.65 (Q2 FY26)
Other Equity:
- As at 31-03-2026 (Audited): ₹411,791.57
Segment-wise Performance [in lakhs]:
Segment Revenue (Standalone) for Q2 FY27:
- Sugar: ₹157,805.50
- Distillery: ₹32,459.36
- Poly lactic Acid (PLA): ₹1,685.33
- Others: ₹586.52
Segment Profit before tax & finance costs (Standalone) for Q2 FY27:
- Sugar: ₹14,075.15 (Profit)
- Distillery: ₹3,912.60 (Profit)
- Poly lactic Acid (PLA): ₹(558.27) (Loss)
- Others: ₹183.97 (Profit)
Corporate Actions:
Dividend: Declared an Interim Dividend of 400% i.e. ₹4.00 per equity share of ₹1 each for FY 2026-27.
Record Date: Wednesday, 11th November, 2026
Payment Date: On and from Thursday, 26th November, 2026
Capital Raising:
- Issued and allotted 93,16,771 equity shares of ₹1 each on a preferential basis at an issue price of ₹483 per share (including a premium of ₹482), aggregating to ₹45,000 lakhs (₹450 Cr).
- ₹32,136.00 lakhs utilised towards the objects of the issue as of 30-09-2026.
- Unutilised balance of ₹12,864.00 lakhs temporarily invested in bank deposits and money market mutual funds.
ESOP Allotment:
- Allotted 3,30,289 equity shares pursuant to the exercise of Employee Stock Appreciation Rights (ESARs) during Q2 FY27.
Other Significant Information:
Capex: Significant Capital Work-in-Progress reported at ₹253,743.12 lakhs (Unaudited as at 30-09-2026).
Seasonality: A note states that sugar is a seasonal industry and quarterly results are not representative of annual performance.